U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 4C6H5O7.3Mo
Molecular Weight 1044.22
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MOLYBDENUM CITRATE

SMILES

[Mo+4].[Mo+4].[Mo+4].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O

InChI

InChIKey=YNNQORGFPVDZOI-UHFFFAOYSA-B
InChI=1S/4C6H8O7.3Mo/c4*7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h4*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;;;;3*+4/p-12

HIDE SMILES / InChI
Molecular Formula Mo
Molecular Weight 95.94
Charge 4
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C6H5O7
Molecular Weight 189.0997
Charge -3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Molybdenum Hexachloride is an inorganic diamagnetic compound used for catalytic polymerization of cycloolefins.

Approval Year

1996
224
PubMed

PubMed

TitleDatePubMed
Study of antitumor effect of selected vanadium and molybdenum organometallic complexes in human leukemic T-cells.
2015-12-05
The Co-induced Effects of Molybdenum and Cadmium on Antioxidants and Heat Shock Proteins in Duck Kidneys.
2015-11
Possible effects of metallosis on spermatozoal apoptotic genes expression in individuals with intramedullary nailing prosthesis.
2014-06
Multiple metals predict prolactin and thyrotropin (TSH) levels in men.
2009-10
Analysis of 35 inorganic elements in teeth in relation to caries formation.
2009
Functional characteristics of NaS2, a placenta-specific Na+-coupled transporter for sulfate and oxyanions of the micronutrients selenium and chromium.
2005-01-25
Molecular basis of proton motive force generation: structure of formate dehydrogenase-N.
2002-03-08
Effects of trace metal compounds on HIV-1 reverse transcriptase: an in vitro study.
1999-05
Patents

Patents

20110207714
7

Sample Use Guides

In Vivo Use Guide
Dietary Considerations Dietary reference intake (IOM, 2011): 0 to 6 months: Adequate intake: 2 mcg daily 7 to 12 months: Adequate intake: 3 mcg daily 1 to 3 years: RDA: 17 mcg daily 4 to 8 years: RDA: 22 mcg daily 9 to 13 years: RDA: 34 mcg daily ≥14 to 18 years: RDA: 43 mcg daily >18 years: RDA: 45 mcg daily Pregnancy and lactation: RDA: 50 mcg daily
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Wed Apr 02 13:51:12 GMT 2025
Edited
by admin
on Wed Apr 02 13:51:12 GMT 2025
Record UNII
BQ2CRB3TW9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Molybdenum citrate [WHO-DD]
Preferred Name English
MOLYBDENUM CITRATE
Common Name English
Code System Code Type Description
CAS
74873-24-8
Created by admin on Wed Apr 02 13:51:12 GMT 2025 , Edited by admin on Wed Apr 02 13:51:12 GMT 2025
NON-SPECIFIC STOICHIOMETRY
PUBCHEM
129690653
Created by admin on Wed Apr 02 13:51:12 GMT 2025 , Edited by admin on Wed Apr 02 13:51:12 GMT 2025
PRIMARY
FDA UNII
BQ2CRB3TW9
Created by admin on Wed Apr 02 13:51:12 GMT 2025 , Edited by admin on Wed Apr 02 13:51:12 GMT 2025
PRIMARY
SMS_ID
100000184289
Created by admin on Wed Apr 02 13:51:12 GMT 2025 , Edited by admin on Wed Apr 02 13:51:12 GMT 2025
PRIMARY
Related Record Type Details
Structure of MOLYBDENUM
PARENT -> SALT/SOLVATE
Structure of Anhydrous citric acid
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of Anhydrous citric acid
ACTIVE MOIETY
Structure of MOLYBDENUM
ACTIVE MOIETY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966